Sun Pharma gets FDA approval for generic Xanax tablets

Sun Pharmaceuticals Industries Ltd said it received abbreviated new drug application (ADNA) from the US Food and Drug Administration (USFDA) approval for its alprazolam tablets a generic version of Xanax.

Alprazolam tablets are used for treatment of anxiety disorder or the short-term relief of symptoms of anxiety. It is also indicated for the treatment of panic disorder, with or without agoraphobia.
These generic alprazolam tablets, equivalent to Pfizer's Xanax tablets, include four strengths: 0.25 mg, 0.5 mg, 1 mg and 2 mg. Annual sale in the US for these strengths of branded and generic alprazolam tablets is estimated at $145 million, the company said in a regulatory filing.

On Friday, Sun Pharma shares ended 0.5% up at Rs1,710 on the Bombay Stock Exchange, while the benchmark Sensex closed 0.3% up at 17,570 points.

User

Lopping off Tax from Principal!

Until now, we told investors that bank fixed deposits, although taxable, would at least ensure...

Premium Content
Monthly Digital Access

Subscribe

Already A Subscriber?
Login
Yearly Digital+Print Access

Subscribe

Moneylife Magazine Subscriber or MSSN member?
Login

Yearly Subscriber Login

Enter the mail id that you want to use & click on Go. We will send you a link to your email for verficiation
Getting on Track

After asking Life Insurance Corporation (LIC) to repeatedly bail out public sector disinvestment...

Premium Content
Monthly Digital Access

Subscribe

Already A Subscriber?
Login
Yearly Digital+Print Access

Subscribe

Moneylife Magazine Subscriber or MSSN member?
Login

Yearly Subscriber Login

Enter the mail id that you want to use & click on Go. We will send you a link to your email for verficiation

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)